Author/Editor		Čokolič, Miro
Title		Vloga atorvastatina v primarni preventivi srčno žilnih bolezni pri diabetikih - izsledki raziskave CARDS
Translated title		The role of atorvastatin in primary prevention of cardiovascular diseases in diabetic patients - CARDS study
Type		članek
Source		In: Židanik S, Tušek-Bunc K, editors. Medicinsko tehnični pripomočki. Zbornik 3. mariborski kongres družinske medicine; 2004 nov 26-27; Maribor. Ljubljana: Združenje zdravnikov družinske medicine SZD,
Publication year		2004
Volume		str. 33-5
Language		slo
Abstract		Type 2 diabetes (DM2) is associated with a two to fourfold excess risk of cardiovascular disease (CVD). Aggressive therapy af diabetic dyslipidemia will reduce the risk of CVD. The CARDS study faund that 10 mg atorvastatin daly reduced the risk of major CV event by 37%, serious heart problems were reduced by 36%, strokes by almost 48%. These benefits were observed even amongst DM2 whose LDL levels were already quite low before treatment. Primary therapy should be directed first at lowering LDL. The initiation level for intervention is LDLHOL>2,6 mmol/l.
Descriptors		DIABETES MELLITUS, NON-INSULIN-DEPENDENT HYPERLIPIDEMIA ANTILIPEMIC AGENTS CARDIOVASCULAR DISEASES PRACTICE GUIDELINES